Old Web
English
Sign In
Acemap
>
authorDetail
>
Myung Hwan Rho
Myung Hwan Rho
Dong-a University
Oncology
Gemcitabine
Medicine
Internal medicine
Pancreatic cancer
3
Papers
63
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer
2015
Cancer Chemotherapy and Pharmacology
In Gyu Hwang
Joung-Soon Jang
Sung Yong Oh
Myung Hwan Rho
Suee Lee
Young Suk Park
Joon Oh Park
Eun Mi Nam
Hyo Rak Lee
Hyun Jung Jun
Kyong Choun Chi
Show All
Source
Cite
Save
Citations (4)
Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
2009
American Journal of Clinical Oncology
Suee Lee
Sung Yong Oh
Byung Geun Kim
Hyuk-Chan Kwon
Sung Hyun Kim
Myung Hwan Rho
Young Hoon Kim
Mee-Sook Rho
Jin-Sook Jeong
Hyojin Kim
Show All
Source
Cite
Save
Citations (49)
Gemcitabine versus Gemcitabine Combined with Cisplatin Treatment Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Analysis
2008
Cancer Research and Treatment
Jae Hyuk Choi
Sung Yong Oh
Hyuk-Chan Kwon
Jung Hwan Kim
Jae-Hoon Lee
Suee Lee
Dong Mee Lee
Sung Hyun Kim
Myung Hwan Rho
Young Hoon Kim
Mee-Sook Rho
Hyo Jin Kim
Show All
Source
Cite
Save
Citations (10)
1